CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,955,086
+$142,356 QoQ
Shares Held
646,256
+17.1% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. VNDA ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,955,086 | 646,256 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,812,730 | 551,770 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,414,542 | 500,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,439,790 | 488,936 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,124,977 | 450,207 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,184,220 | 475,865 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,674,956 | 558,446 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,796,224 | 596,210 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,348,964 | 592,737 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,746,219 | 668,180 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,722,444 | 645,129 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,791,791 | 646,248 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,204,894 | 638,072 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,293,704 | 632,357 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,914,608 | 665,035 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,371,177 | 644,856 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,915,810 | 634,478 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,683,810 | 679,382 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,097,411 | 707,292 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,967,577 | 639,882 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 ALXN | — | 1,061,176 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $11,936,049 | 554,907 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 ALXN | — | 1,033,583 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $6,171,072 | 410,857 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 ALXN | — | 1,086,933 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $4,681,545 | 356,282 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 1,316,188 | Shares | Sole | 2020-11-13 | |
| 2020-09-30 | $3,424,962 | 354,551 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 ALXN | — | 1,427,239 | Shares | Sole | 2020-08-20 | |
| 2020-06-30 | $4,066,622 | 355,474 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 ALXN | — | 1,364,034 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $3,403,270 | 328,501 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||